Change Password!
Reset Password!
The CDC now recommends Doxycycline for some patients to prevent sexually transmitted infections when taken within 72 hours of intimate contact.
In a move aimed at bolstering sexual health, the US Centers for Disease Control and Prevention (CDC) has unveiled new guidelines advocating for Doxycycline as a preventive measure against sexually transmitted infections (STIs).
The guidelines target men who have intercourse with men and transgender women with a past of bacterial STIs like syphilis, chlamydia or gonorrhoea within the last year. For those who haven’t recently had an STI but are at high risk, clinicians are advised to discuss Doxycycline postexposure prophylaxis or doxyPEP.
The CDC’s updated recommendations present as a proactive approach to STI prevention, especially for individuals at elevated risk, and encourage healthcare providers to discuss doxyPEP with eligible patients.
JAMA
CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US
Emily Harris
Comments (0)